Patriot Financial Group Insurance Agency’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6
Closed 1136
2022
Q2
$0 Hold
6
﹤0.01% 2093
2022
Q1
$0 Hold
6
﹤0.01% 2142
2021
Q4
$0 Hold
6
﹤0.01% 2199
2021
Q3
$1K Hold
6
﹤0.01% 2060
2021
Q2
$1K Hold
6
﹤0.01% 1983
2021
Q1
$1K Hold
6
﹤0.01% 1886
2020
Q4
$1K Hold
6
﹤0.01% 1759
2020
Q3
$1K Hold
6
﹤0.01% 1555
2020
Q2
$2K Buy
+6
New +$963 ﹤0.01% 1395
2019
Q4
Sell
-83
Closed -$2K 1376
2019
Q3
$2K Hold
83
﹤0.01% 1095
2019
Q2
$3K Hold
83
﹤0.01% 1042
2019
Q1
$4K Buy
+83
New +$4.18K ﹤0.01% 896

Other funds holding INO

Patriot Financial Group Insurance Agency's INO Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Inovio Pharmaceuticals (INO) in Q3 2022, closing a stake of 6 shares.

Patriot Financial Group Insurance Agency first reported a position in INO in Q1 2019 and held it in 12 quarters. The position peaked at $4K in Q1 2019. 182 funds tracked by Wall St. Rank hold INO as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Inovio Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 6 Inovio Pharmaceuticals shares in Q3 2022.
  • Patriot Financial Group Insurance Agency first reported a position in Inovio Pharmaceuticals in Q1 2019 and held it in 12 quarters.
  • Patriot Financial Group Insurance Agency's Inovio Pharmaceuticals position peaked at $4K in Q1 2019.
  • 182 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.